First published 2 September 2013
The use of Agent-based Simulation to Discover Extreme Cases in Immune-Interactions with Early-Stage Cancer Scenarios
Grazziela Figueredo, Peer-Olaf Siebers, Douglas Augusto, Helio Barbosa, Uwe Aickelin
Early-stage cancer and its interactions with the immune system are still not fully understood. In order to better understand these processes, researchers employ different methods. Simulation and in particular, agent-based simulation (ABS) have been found useful tools for understanding it (Look et al., 1981; Castiglione et al., 1999, 2001; Bonabeau, 2002; Figueredo and Aickelin, 2011; Figueredo et al., 2013a,b).